<SEC-DOCUMENT>0001209191-18-020920-index.html : 20180320
<SEC-HEADER>0001209191-18-020920.hdr.sgml : 20180320
<ACCEPTANCE-DATETIME>20180320170216
ACCESSION NUMBER:		0001209191-18-020920
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180316
FILED AS OF DATE:		20180320
DATE AS OF CHANGE:		20180320

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ali-Jackson Kamil
		CENTRAL INDEX KEY:			0001654337

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37581
		FILM NUMBER:		18702503

	MAIL ADDRESS:	
		STREET 1:		C/O ACLARIS THERAPEUTICS, INC.
		STREET 2:		101 LINDENWOOD DRIVE, SUITE 400
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-321-5554

	MAIL ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>